Patients with psoriatic arthritis who received GLP-1 receptor agonists exhibited lower risks for mortality and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback